Overall, the data presented here show that decreased SphK1 levels in AD neurons worsen microglia function, resulting in failure of resolution and exacerbation of AD pathology, namely Aβ plaque deposition and cognitive impairment (Supplementary Fig. 17). Here, SPHK1 is linked to Alzheimer disease.